ReviewOrthopaedic surgery2026
The High-Intensity Zone: A Dynamic Inflammatory Hub in Lumbar Disc Degeneration.
Review in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The lumbar intervertebral disc high-intensity zone (HIZ), a focal hyperintensity within the annulus fibrosus on T2-weighted magnetic resonance imaging, has garnered significant attention as a critical imaging biomarker in the pathological cascade of lumbar disc degeneration (LDD). This review systematically delineates the pathological basis of the HIZ and provides a comprehensive dissection of the molecular pathways it shares with LDD. while also summarizing recent advancements in artificial intelligence and multimodal imaging for enhancing HIZ detection and characterization. The HIZ is positioned as a "dynamic inflammatory hub" characterized by vascularized granulation tissue infiltration, nerve ingrowth, and a localized chronic inflammatory response following annular fissures. The molecular pathology involves a self-perpetuating "inflammation-matrix degradation" vicious cycle driven by cytokines (e.g., TNF-α, IL-1β) and matrix-degrading enzymes (e.g., MMPs, ADAMTS), underscoring its central role in the chronicization of discogenic low back pain (DLBP). Although the HIZ exhibits high specificity for diagnosing DLBP, its utility is constrained by limited sensitivity, false positives, and a notable dissociation from clinical symptoms. Furthermore, a stratified and diversified therapeutic blueprint is outlined, ranging from physical ablation and nucleus pulposus replacement to biologic agents (e.g., platelet-rich plasma), regenerative medicine (e.g., stem cell therapy), and cutting-edge nanotechnologies. Moving beyond conventional morphology to integrate advanced diagnostic technologies is imperative. Looking forward, integrating molecular imaging, single-cell omics, and precision medicine strategies to target the HIZ microenvironment offers a promising new paradigm for disrupting the "inflammation-degeneration-pain" cycle, restoring disc homeostasis, and achieving precise diagnosis and treatment of DLBP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.